Skip to main content
. Author manuscript; available in PMC: 2023 Feb 15.
Published in final edited form as: Am J Cardiol. 2021 Dec 17;165:46–50. doi: 10.1016/j.amjcard.2021.10.051

Table 2:

Association of Cannabis Use and ASCVD Risk Category

Cannabis Use Reference Level ASCVD Risk Category
Borderline Intermediate High
OR (95% CI) OR (95% CI) OR (95% CI)
Ever User Never User 1.51 (1.23–1.84, p<0.001) 1.49 (1.26–1.78, p<0.001) 1.60 (1.04–2.45, p=0.03)
Current User Never User 1.32 (1.01–1.72, p=0.04) 1.37 (1.09–1.73, p=0.007) 1.41 (0.80–2.51, p=0.24)
Every month for ≥ 1 year Never User 1.73 (1.38–2.16, p<0.001) 1.96 (1.62–2.37, p<0.001) 1.87 (1.16–3.00, p=0.01)
≥ 2 uses per month Never User 1.78 (1.43–2.23, p<0.001) 1.90 (1.56–2.30, p<0.001) 1.79 (1.10–2.92, p=0.02)
≥ 1 use per day Never User 1.72 (1.38–2.16, p<0.001) 1.94 (1.60–2.35, p<0.001) 1.87 (1.16–3.01, p<0.001)

OR (95% CI) = Odds Ratio (95% Confidence Interval); ASCVD = atherosclerotic cardiovascular disease;

Borderline = ASCVD score 5.0–7.4%; Intermediate = ASCVD score 7.5%−19.9%; High = ASCVD score ≥20%